{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T03:41:13Z","timestamp":1762659673142},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,21]],"date-time":"2018-05-21T00:00:00Z","timestamp":1526860800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12931-018-0803-2","type":"journal-article","created":{"date-parts":[[2018,5,21]],"date-time":"2018-05-21T11:57:32Z","timestamp":1526903852000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Soluble urokinase plasminogen activator receptor predicts mortality in exacerbated COPD"],"prefix":"10.1186","volume":"19","author":[{"given":"Nina S.","family":"Godtfredsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ditte V.","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristoffer","family":"Marsaa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte S.","family":"Ulrik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ove","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesper","family":"Eugen-Olsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Line J. H.","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,21]]},"reference":[{"key":"803_CR1","unstructured":"From the Global Strategy for the Diagnosis, Management and prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017. p. 7. Available from: \n                    http:\/\/goldcopd.org\n                    \n                  . Accessed 6 Sept 2017."},{"key":"803_CR2","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1183\/09031936.00043814","volume":"44","author":"D Stolz","year":"2014","unstructured":"Stolz D, Meyer A, Rakic J, Boeck L, Scherr A, Tamm M. Mortality risk prediction in COPD by a prognostic biomarker panel. Eur Respir J. 2014;44:1557\u201370.","journal-title":"Eur Respir J"},{"key":"803_CR3","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1056\/NEJMoa0909883","volume":"363","author":"JR Hurst","year":"2010","unstructured":"Hurst JR, Vestbo J, Anzueto A, Locantore N, M\u00fcllerova H, Tal-Singer R, et al. Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363:1128\u201338.","journal-title":"N Engl J Med"},{"key":"803_CR4","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1378\/chest.14-0655","volume":"147","author":"H M\u00fcllerova","year":"2015","unstructured":"M\u00fcllerova H, Maselli DJ, Locantore N, Vestbo J, Hurst JR, Wedzicha JA, et al. Hospitalized exacerbations of COPD: risk factors and outcomes in the ECLIPSE cohort. Chest. 2015;147:999\u20131007.","journal-title":"Chest"},{"key":"803_CR5","first-page":"1","volume":"5","author":"FK Lomholt","year":"2014","unstructured":"Lomholt FK, Laulund AS, Bjarnason NH, J\u00f8rgensen HL, Godtfredsen NS. Meta-analysis of routine blood tests as predictors of mortality in COPD. Eur Clin Respir J. 2014;5:1.","journal-title":"Eur Clin Respir J"},{"key":"803_CR6","doi-asserted-by":"publisher","first-page":"e0158843","DOI":"10.1371\/journal.pone.0158843","volume":"11","author":"YW Chen","year":"2016","unstructured":"Chen YW, Leung JM, Sin DD. A systematic review of diagnostic biomarkers of COPD exacerbation. PLoS One. 2016;11:e0158843.","journal-title":"PLoS One"},{"key":"803_CR7","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1136\/thoraxjnl-2016-209298","volume":"72","author":"C Echevarria","year":"2017","unstructured":"Echevarria C, Steer J, Heslop-Marshall K, Stenton SC, Hickey PM, Hughes R, et al. The PEARL score predicts 90-day readmission or death after hospitalisation for acute exacerbation of COPD. Thorax. 2017;72:686\u201393.","journal-title":"Thorax"},{"key":"803_CR8","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1177\/147323001204000316","volume":"40","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Xiao W, Jiang Y, Wang H, Xu X, Ma D, et al. Levels of components of the urokinase-type plasminogen activator system are related to chronic obstructive pulmonary disease parenchymal destruction and airway remodelling. J Int Med Res. 2012;40:976\u201385.","journal-title":"J Int Med Res"},{"key":"803_CR9","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/1465-9921-14-67","volume":"14","author":"Q Wang","year":"2013","unstructured":"Wang Q, Wang Y, Zhang Y, Zhang Y, Xiao W. The role of uPAR in epithelial-mesenchymal transition in small airway epithelium of patients with chronic obstructive pulmonary disease. Respir Res. 2013;14:67. \n                    https:\/\/doi.org\/10.1186\/1465-9921-14-67\n                    \n                  .","journal-title":"Respir Res"},{"key":"803_CR10","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1164\/rccm.200703-390OC","volume":"177","author":"IM Wang","year":"2008","unstructured":"Wang IM, Stepaniants S, Boie Y, Mortimer JR, Kennedy B, Elliott M, et al. Gene expression profiling in patients with chronic obstructive pulmonary disease and lung cancer. Am J Respir Crit Care Med. 2008;177:402\u201311.","journal-title":"Am J Respir Crit Care Med"},{"key":"803_CR11","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1007\/s00134-012-2613-1","volume":"38","author":"Y Backes","year":"2012","unstructured":"Backes Y, van der Sluijs KF, Mackie DP, Tacke F, Koch A, Tenhunen JJ, et al. Usefulness of suPAR as a biological marker in patients with systemic inflammation or infection: a systematic review. Intensive Care Med. 2012;38:1418\u201328.","journal-title":"Intensive Care Med"},{"key":"803_CR12","first-page":"357","volume":"10","author":"A Gumus","year":"2015","unstructured":"Gumus A, Altintas N, Cinarka H, Kirbas A, Haz\u0131roglu M, Karatas M, et al. Soluble urokinase-type plasminogen activator receptor is a novel biomarker predicting acute exacerbations i COPD. Int J Chron Obstruct Pulmon Dis. 2015;10:357\u201365.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"803_CR13","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1097\/JIM.0000000000000105","volume":"62","author":"\u00dc Can","year":"2014","unstructured":"Can \u00dc, G\u00fczelant A, Yerlikaya FH, Yosunkaya \u015e. The role of serum soluble urokinase-type plasminogen activator receptor in stable chronic obstructive pulmonary disease. J Investig Med. 2014;62:938\u201343.","journal-title":"J Investig Med"},{"key":"803_CR14","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/j.1365-2796.2010.02252.x","volume":"268","author":"J Eugen-Olsen","year":"2010","unstructured":"Eugen-Olsen J, Andersen O, Linneberg A, Ladelund S, Hansen TW, Langkilde A, et al. Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population. J Intern Med. 2010;268:296\u2013308.","journal-title":"J Intern Med"},{"key":"803_CR15","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1136\/emermed-2015-205444","volume":"33","author":"LJH Rasmussen","year":"2016","unstructured":"Rasmussen LJH, Ladelund S, Haupt TH, Ellekilde G, Poulsen JH, Iversen K, et al. Soluble urokinase plasminogen activator receptor (suPAR) in acute care: a strong marker of disease presence and severity, readmission and mortality. A retrospective cohort study. Emerg Med J. 2016;33:769\u201375.","journal-title":"Emerg Med J"},{"key":"803_CR16","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1177\/1403494811401482","volume":"39","author":"E Lynge","year":"2011","unstructured":"Lynge E, Sandegaard JL, Rebolj M. The Danish National Patient Register. Scand J Public Health. 2011;39:30\u20133.","journal-title":"Scand J Public Health."},{"key":"803_CR17","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1177\/1403494810387965","volume":"39","author":"CB Pedersen","year":"2011","unstructured":"Pedersen CB. The Danish civil registration system. Scand J Public Health. 2011;39:22\u20135.","journal-title":"Scand J Public Health"},{"key":"803_CR18","doi-asserted-by":"publisher","first-page":"R130","DOI":"10.1186\/cc11434","volume":"16","author":"TH Haupt","year":"2012","unstructured":"Haupt TH, Petersen J, Ellekilde G, Klausen HH, Thorball CW, Eugen-Olsen J, et al. Plasma suPAR levels are associated with mortality, admission time, and Charlson Comorbidity Index in the acutely admitted medical patient: a prospective observational study. Crit Care. 2012;16:R130.","journal-title":"Crit Care"},{"key":"803_CR19","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/aje\/kwq433","volume":"173","author":"H Quan","year":"2011","unstructured":"Quan H, Li B, Couris CM, Fushimi K, Graham P, Hider P, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173:676\u201382.","journal-title":"Am J Epidemiol"},{"issue":"1","key":"803_CR20","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12931-017-0597-7","volume":"18","author":"RL Zemans","year":"2017","unstructured":"Zemans RL, Jacobson S, Keene J, Kechris K, Miller BE, Tal-Singer R, et al. Multiple biomarkers predict disease severity, progression and mortality in COPD. Respir Res. 2017;18(1):117. \n                    https:\/\/doi.org\/10.1186\/s12931-017-0597-7\n                    \n                  .","journal-title":"Respir Res"},{"key":"803_CR21","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1136\/thoraxjnl-2011-201518","volume":"67","author":"S Suissa","year":"2012","unstructured":"Suissa S, Dell\u2019Aniello S, Ernst P. Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality. Thorax. 2012;67:957\u201363.","journal-title":"Thorax"},{"key":"803_CR22","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/j.1365-2796.2012.02569.x","volume":"272","author":"R Uusitalo-Sepp\u00e4l\u00e4","year":"2012","unstructured":"Uusitalo-Sepp\u00e4l\u00e4 R, Huttunen R, Tarkka M, Aittoniemi J, Koskinen P, Leino A, et al. Soluble urokinase-type plasminogen activator receptor in patients with suspected infection in the emergency room: a prospective cohort study. J Intern Med. 2012;272:247\u201356.","journal-title":"J Intern Med"},{"key":"803_CR23","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1111\/joim.12238","volume":"276","author":"RB Raggam","year":"2014","unstructured":"Raggam RB, Wagner J, Pr\u00fcller F, Grisold A, Leitner E, Zollner-Schwetz I, et al. Soluble urokinase plasminogen activator receptor predicts mortality in patients with systemic inflammatory response syndrome. J Intern Med. 2014;276:651\u20138.","journal-title":"J Intern Med"},{"key":"803_CR24","doi-asserted-by":"publisher","first-page":"39481","DOI":"10.1038\/srep39481","volume":"6","author":"W Ni","year":"2016","unstructured":"Ni W, Han Y, Zhao J, Cui J, Wang K, Wang R, et al. Serum soluble urokinase-type plasminogen activator receptor as a biological marker of bacterial infection in adults: a systematic review and meta-analysis. Sci Rep. 2016;6:39481. \n                    https:\/\/doi.org\/10.1038\/srep39481\n                    \n                  .","journal-title":"Sci Rep"},{"key":"803_CR25","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.jchf.2016.12.008","volume":"5","author":"L Koller","year":"2017","unstructured":"Koller L, Stojkovic S, Richter B, Sulzgruber P, Potolidis C, Liebhart F, et al. Soluble urokinase-type plasminogen activator receptor improves risk prediction in patients with chronic heart failure. JACC Heart Fail. 2017;5:268\u201377.","journal-title":"JACC Heart Fail"},{"key":"803_CR26","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1373\/clinchem.2013.203778","volume":"59","author":"S Lyngb\u00e6k","year":"2013","unstructured":"Lyngb\u00e6k S, Andersson C, Marott JL, M\u00f8ller DV, Christiansen M, Iversen KK, et al. Soluble urokinase plasminogen activator receptor for risk prediction in patients admitted with acute chest pain. Clin Chem. 2013;59:1621\u20139.","journal-title":"Clin Chem"},{"key":"803_CR27","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.2147\/COPD.S107409","volume":"11","author":"H Wang","year":"2016","unstructured":"Wang H, Yang T, Li D, Wu Y, Zhang X, Pang C, et al. Elevated circulating PAI-1 levels are related to lung function decline, systemic inflammation, and small airway obstruction in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2016;11:2369\u201376.","journal-title":"Int J Chron Obstruct Pulmon Dis."},{"key":"803_CR28","first-page":"21","volume":"11","author":"ID Pavord","year":"2016","unstructured":"Pavord ID, Jones PW, Burgel PR, Rabe KF. Exacerbations of COPD. Int J Chron Obstruct Pulmon Dis. 2016;11:21\u201330.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"803_CR29","doi-asserted-by":"publisher","first-page":"CD004104","DOI":"10.1002\/14651858.CD004104.pub4.","volume":"7","author":"CR Osadnik","year":"2017","unstructured":"Osadnik CR, Tee VS, Carson-Chahhoud KV, Picot J, Wedzicha JA, Smith BJ. Non-invasive ventilation for the management of acute hypercapnic respiratory failure due to exacerbation of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2017;7:CD004104. \n                    https:\/\/doi.org\/10.1002\/14651858.CD004104.pub4.","journal-title":"Cochrane Database Syst Rev"},{"key":"803_CR30","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.rmed.2015.02.013","volume":"109","author":"M Brusse-Keizer","year":"2015","unstructured":"Brusse-Keizer M, Zuur-Telgen M, van der Palen J, VanderValk P, Kerstjens H, Boersma W, et al. Adrenomedullin optimises mortality prediction in COPD patients. Respir Med. 2015;109:734\u201342.","journal-title":"Respir Med"},{"key":"803_CR31","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1136\/thoraxjnl-2012-202103","volume":"67","author":"J Steer","year":"2012","unstructured":"Steer J, Gibson J, Bourke SC. The DECAF score: predicting hospital mortality in exacerbations of chronic obstructive pulmonary disease. Thorax. 2012;67:970\u20136.","journal-title":"Thorax"},{"key":"803_CR32","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1080\/15412555.2017.1343814","volume":"14","author":"A Vanasse","year":"2017","unstructured":"Vanasse A, Courteau J, Couillard S, Beauchesne MF, Lariv\u00e9e P. Predicting one-year mortality after a \u201cfirst\u201d hospitalization for chronic obstructive pulmonary disease: an eight-variable assessment score tool. COPD. 2017;14:490\u20137.","journal-title":"COPD."},{"key":"803_CR33","doi-asserted-by":"publisher","unstructured":"Ouchi K, Jambaulikar G, George NR, Xu W, Obermeyer Z, Aaronson EL, et al. The \u201csurprise question\u201d asked of emergency physicians may predict 12-month mortality among older emergency department patients. J Palliat Med. 2017; \n                    https:\/\/doi.org\/10.1089\/jpm.2017.0192.","DOI":"10.1089\/jpm.2017.0192."},{"key":"803_CR34","doi-asserted-by":"publisher","first-page":"91","DOI":"10.4137\/BMI.S19876","volume":"9","author":"TH Haupt","year":"2014","unstructured":"Haupt TH, Kallemose T, Ladelund S, Rasmussen LJ, Thorball CW, Andersen O, et al. Risk factors associated with serum levels of the inflammatory biomarker soluble urokinase plasminogen activator receptor in a general population. Biomark Insights. 2014;9:91\u2013100.","journal-title":"Biomark Insights"},{"key":"803_CR35","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1080\/15412550903140865","volume":"6","author":"AS Gershon","year":"2009","unstructured":"Gershon AS, Wang C, Guan J, Vasilevska-Ristovska J, Cicutto L, To T. Identifying individuals with physcian diagnosed COPD in health administrative databases. COPD. 2009;6:388\u201394.","journal-title":"COPD"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-018-0803-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12931-018-0803-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-018-0803-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,20]],"date-time":"2019-05-20T23:11:17Z","timestamp":1558393877000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-018-0803-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,21]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["803"],"URL":"https:\/\/doi.org\/10.1186\/s12931-018-0803-2","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,21]]},"assertion":[{"value":"23 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Danish Health and Medicines Authority (ref. no. 3\u20133013-1061\/1) and by the Danish Data Protection Agency (ref.no. HVH-2014-018, 02767).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"NSG, DVJ, KM, CSU and LJHR have nothing to declare. JE-O and OA have invented patents on suPAR and prognosis. The patents are owned by Amager and Hvidovre Hospital, Denmark and licensed to ViroGates A\/S. JE-O is co-founder, shareholder and CSO of ViroGates A\/S.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"97"}}